Jenike M A, Baer L, Summergrad P, Weilburg J B, Holland A, Seymour R
Harvard Medical School and Massachusetts General Hospital, Boston 02114.
Am J Psychiatry. 1989 Oct;146(10):1328-30. doi: 10.1176/ajp.146.10.1328.
Clomipramine was significantly superior to placebo in a 10-week double-blind, placebo-controlled trial in 27 outpatients who met DSM-III-R criteria for obsessive-compulsive disorder.